Bain B J, Chapman C
Department of Haematology, Leicester Royal Infirmary Children's Hospital, UK.
J Clin Pathol. 1998 May;51(5):382-9. doi: 10.1136/jcp.51.5.382.
To document current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis and to compare such practice with guidelines published by the British Committee for Standards in Haematology and the Standing Committee on Sickle Cell, Thalassaemia and other Haemoglobinopathies (SMAC).
The members of the UK Forum on Haemoglobin Disorders were surveyed about their current practice for antenatal haemoglobinopathy screening. The UK Forum is a national group of haematologists, paediatricians, laboratory scientists, and counsellors working in the field of diagnosis and management of disorders of haemoglobin synthesis; such disorders including the alpha and beta thalassaemias, sickle cell disease, and other haemoglobinopathies.
Completed questionnaires from 38 hospitals (or cooperating groups of hospitals) were analysed. The great majority of hospitals were applying appropriate laboratory methods, but problems were commonly encountered in ensuring that appropriate testing of antenatal patients and, when necessary, of their partners, was carried out early in pregnancy. When screening was selective there was quite often a failure to identify all women in whom testing was indicated, and cut off points used as an indication for further testing were sometimes inappropriate.
Many practical problems are still encountered in following guidelines for the antenatal diagnosis of haemoglobinopathies. A need for improved administrative procedures and increased funding was identified. In addition there is a need for agreed guidelines giving more specific advice on technical aspects of laboratory practice.
记录英国目前对珠蛋白链合成遗传性疾病进行产前筛查的做法,并将这种做法与英国血液学标准委员会以及镰状细胞、地中海贫血和其他血红蛋白病常务委员会(SMAC)发布的指南进行比较。
对英国血红蛋白病论坛的成员进行了调查,了解他们目前进行产前血红蛋白病筛查的做法。英国论坛是一个由从事血红蛋白合成疾病诊断和管理领域工作的血液学家、儿科医生、实验室科学家和咨询师组成的全国性团体;这些疾病包括α和β地中海贫血、镰状细胞病和其他血红蛋白病。
分析了来自38家医院(或合作医院组)的完整问卷。绝大多数医院都采用了适当的实验室方法,但在确保对产前患者及其必要时对其伴侣进行适当检测在妊娠早期进行方面,普遍遇到问题。当筛查具有选择性时,常常未能识别出所有需要检测的女性,并且用作进一步检测指征的临界值有时并不合适。
在遵循血红蛋白病产前诊断指南方面,仍然遇到许多实际问题。确定需要改进行政程序并增加资金。此外,还需要商定的指南,就实验室操作的技术方面提供更具体的建议。